vs

Side-by-side financial comparison of Harmony Biosciences Holdings, Inc. (HRMY) and Ribbon Communications Inc. (RBBN). Click either name above to swap in a different company.

Harmony Biosciences Holdings, Inc. is the larger business by last-quarter revenue ($243.8M vs $162.6M, roughly 1.5× Ribbon Communications Inc.). Ribbon Communications Inc. runs the higher net margin — 54.8% vs 9.2%, a 45.5% gap on every dollar of revenue. On growth, Harmony Biosciences Holdings, Inc. posted the faster year-over-year revenue change (21.1% vs -10.3%). Over the past eight quarters, Harmony Biosciences Holdings, Inc.'s revenue compounded faster (25.6% CAGR vs -8.1%).

Harmony Biosciences Holdings, Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for rare neurological and central nervous system disorders. Its primary market is the United States, with its core product serving patients living with narcolepsy and other sleep-related CNS conditions across adult and pediatric segments.

Ribbon Communications Inc. is a public company that makes software, IP and optical networking solutions for service providers, enterprises and critical infrastructure sectors. The company was formed in 2017, following the merger of Genband and Sonus Networks and is headquartered in Plano, Texas.

HRMY vs RBBN — Head-to-Head

Bigger by revenue
HRMY
HRMY
1.5× larger
HRMY
$243.8M
$162.6M
RBBN
Growing faster (revenue YoY)
HRMY
HRMY
+31.4% gap
HRMY
21.1%
-10.3%
RBBN
Higher net margin
RBBN
RBBN
45.5% more per $
RBBN
54.8%
9.2%
HRMY
Faster 2-yr revenue CAGR
HRMY
HRMY
Annualised
HRMY
25.6%
-8.1%
RBBN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
HRMY
HRMY
RBBN
RBBN
Revenue
$243.8M
$162.6M
Net Profit
$22.5M
$89.1M
Gross Margin
71.9%
42.9%
Operating Margin
15.8%
37.6%
Net Margin
9.2%
54.8%
Revenue YoY
21.1%
-10.3%
Net Profit YoY
-54.6%
EPS (diluted)
$0.38
$0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HRMY
HRMY
RBBN
RBBN
Q1 26
$162.6M
Q4 25
$243.8M
$227.3M
Q3 25
$239.5M
$215.4M
Q2 25
$200.5M
$220.6M
Q1 25
$184.7M
$181.3M
Q4 24
$201.3M
$251.4M
Q3 24
$186.0M
$210.2M
Q2 24
$172.8M
$192.6M
Net Profit
HRMY
HRMY
RBBN
RBBN
Q1 26
$89.1M
Q4 25
$22.5M
Q3 25
$50.9M
$-12.1M
Q2 25
$39.8M
$-11.1M
Q1 25
$45.6M
$-26.2M
Q4 24
$49.5M
Q3 24
$46.1M
$-13.4M
Q2 24
$11.6M
$-16.8M
Gross Margin
HRMY
HRMY
RBBN
RBBN
Q1 26
42.9%
Q4 25
71.9%
53.3%
Q3 25
75.1%
50.1%
Q2 25
81.0%
49.6%
Q1 25
82.7%
45.4%
Q4 24
73.0%
55.7%
Q3 24
77.0%
52.1%
Q2 24
81.4%
50.8%
Operating Margin
HRMY
HRMY
RBBN
RBBN
Q1 26
37.6%
Q4 25
15.8%
4.1%
Q3 25
27.3%
1.3%
Q2 25
24.0%
1.9%
Q1 25
30.4%
-10.8%
Q4 24
27.7%
13.2%
Q3 24
33.2%
-0.4%
Q2 24
12.4%
-1.0%
Net Margin
HRMY
HRMY
RBBN
RBBN
Q1 26
54.8%
Q4 25
9.2%
Q3 25
21.2%
-5.6%
Q2 25
19.8%
-5.0%
Q1 25
24.7%
-14.5%
Q4 24
24.6%
Q3 24
24.8%
-6.4%
Q2 24
6.7%
-8.7%
EPS (diluted)
HRMY
HRMY
RBBN
RBBN
Q1 26
$0.50
Q4 25
$0.38
$0.50
Q3 25
$0.87
$-0.07
Q2 25
$0.68
$-0.06
Q1 25
$0.78
$-0.15
Q4 24
$0.85
$0.05
Q3 24
$0.79
$-0.08
Q2 24
$0.20
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HRMY
HRMY
RBBN
RBBN
Cash + ST InvestmentsLiquidity on hand
$775.3M
$67.6M
Total DebtLower is stronger
$163.7M
Stockholders' EquityBook value
$870.2M
$419.1M
Total Assets
$1.3B
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HRMY
HRMY
RBBN
RBBN
Q1 26
$67.6M
Q4 25
$775.3M
$96.4M
Q3 25
$672.6M
$74.8M
Q2 25
$565.3M
$60.5M
Q1 25
$507.0M
$71.2M
Q4 24
$467.2M
$87.8M
Q3 24
$410.5M
$37.2M
Q2 24
$346.9M
$64.6M
Total Debt
HRMY
HRMY
RBBN
RBBN
Q1 26
Q4 25
$163.7M
$342.1M
Q3 25
$168.5M
$344.3M
Q2 25
$172.1M
$346.5M
Q1 25
$175.7M
$347.4M
Q4 24
$179.3M
$348.3M
Q3 24
$182.8M
$349.1M
Q2 24
$186.4M
$350.0M
Stockholders' Equity
HRMY
HRMY
RBBN
RBBN
Q1 26
$419.1M
Q4 25
$870.2M
$449.0M
Q3 25
$835.1M
$360.1M
Q2 25
$773.1M
$370.4M
Q1 25
$720.5M
$381.8M
Q4 24
$659.2M
$404.6M
Q3 24
$596.8M
$395.5M
Q2 24
$538.6M
$405.0M
Total Assets
HRMY
HRMY
RBBN
RBBN
Q1 26
Q4 25
$1.3B
$1.2B
Q3 25
$1.2B
$1.1B
Q2 25
$1.1B
$1.1B
Q1 25
$1.1B
$1.1B
Q4 24
$999.2M
$1.2B
Q3 24
$928.1M
$1.1B
Q2 24
$858.4M
$1.1B
Debt / Equity
HRMY
HRMY
RBBN
RBBN
Q1 26
Q4 25
0.19×
0.76×
Q3 25
0.20×
0.96×
Q2 25
0.22×
0.94×
Q1 25
0.24×
0.91×
Q4 24
0.27×
0.86×
Q3 24
0.31×
0.88×
Q2 24
0.35×
0.86×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HRMY
HRMY
RBBN
RBBN
Operating Cash FlowLast quarter
$126.2M
Free Cash FlowOCF − Capex
$126.0M
FCF MarginFCF / Revenue
51.7%
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
5.61×
TTM Free Cash FlowTrailing 4 quarters
$347.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HRMY
HRMY
RBBN
RBBN
Q1 26
Q4 25
$126.2M
$29.2M
Q3 25
$108.7M
$26.5M
Q2 25
$79.3M
$-795.0K
Q1 25
$34.0M
$-3.5M
Q4 24
$75.6M
$61.8M
Q3 24
$70.5M
$-14.8M
Q2 24
$42.6M
$-9.8M
Free Cash Flow
HRMY
HRMY
RBBN
RBBN
Q1 26
Q4 25
$126.0M
$27.3M
Q3 25
$108.7M
$21.0M
Q2 25
$79.3M
$-6.5M
Q1 25
$33.9M
$-15.7M
Q4 24
$75.0M
$53.8M
Q3 24
$70.5M
$-23.7M
Q2 24
$42.0M
$-12.9M
FCF Margin
HRMY
HRMY
RBBN
RBBN
Q1 26
Q4 25
51.7%
12.0%
Q3 25
45.4%
9.7%
Q2 25
39.6%
-2.9%
Q1 25
18.3%
-8.7%
Q4 24
37.3%
21.4%
Q3 24
37.9%
-11.3%
Q2 24
24.3%
-6.7%
Capex Intensity
HRMY
HRMY
RBBN
RBBN
Q1 26
Q4 25
0.0%
0.9%
Q3 25
0.0%
2.6%
Q2 25
0.0%
2.6%
Q1 25
0.1%
6.7%
Q4 24
0.3%
3.2%
Q3 24
0.0%
4.2%
Q2 24
0.4%
1.6%
Cash Conversion
HRMY
HRMY
RBBN
RBBN
Q1 26
Q4 25
5.61×
Q3 25
2.14×
Q2 25
1.99×
Q1 25
0.75×
Q4 24
1.53×
Q3 24
1.53×
Q2 24
3.68×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HRMY
HRMY

Segment breakdown not available.

RBBN
RBBN

Service$94.5M58%
Product$68.1M42%

Related Comparisons